C4 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Preliminary Monotherapy Data from the Ongoing CFT1946 Phase 1 Trial in BRAF V600X Solid Tumors to be Presented at ESMO...
PR News
Cibus to Report Second Quarter 2024 Financial Results on August 8, 2024 After the Market Close and Host Conference Call
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and...
CAMTEK ANNOUNCES RESULTS FOR THE SECOND QUARTER OF 2024
Record revenues of $103 million; Q3 revenue guidance of $107-110 million, up ~35% YoY, driven by High Performance Computing applications...
Barfresh Expands Annual Production Capacity by Additional 50 million Units with New Third Party Location with Ability for Further Future Expansion
Location Primarily Dedicated to Manufacturing Company’s New Pop & Go™ Freeze PopsCompany Has Recently Added Three New Third Party Locations...
Blueprint Medicines Reports Second Quarter 2024 Results and Raises AYVAKIT®/AYVAKYT® (avapritinib) Full Year Revenue Guidance
-- Achieved $114.1 million in AYVAKIT net product revenues in the second quarter 2024 -- -- Raising AYVAKIT net product revenue...
Grizzly Industrial Selects Bridgeline’s HawkSearch
WOBURN, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- Bridgeline Digital, Inc. (NASDAQ: BLIN), a provider of marketing software, today announced...
Bitfarms Provides July 2024 Production and Operations Update
- Earned 253 BTC in July 2024 & Increased HODL to 1,016 BTC -- Increased Operational Hashrate to 11.1 EH/s...
Bilibili Inc. to Report Second Quarter 2024 Financial Results on Thursday, August 22, 2024
SHANGHAI, China, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI and HKEX: 9626), an...
BigCommerce Announces Exchange of a Portion of its Existing 0.25% Convertible Senior Notes due 2026 for New 7.5% Convertible Senior Notes due 2028 and Repurchases of a Portion of its Existing 0.25% Convertible Senior Notes due 2026
AUSTIN, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- BigCommerce Holdings, Inc. (“BigCommerce” or the “Company”) (NASDAQ: BIGC) today announced that...
Bandwidth Announces Second Quarter 2024 Financial Results
Revenue of $174 million, up 19% year-over-year Accelerating profitability, exceeding guidance Expanding cash flow generation RALEIGH, N.C., Aug. 1, 2024...
Aurinia Pharmaceuticals Reports Second Quarter and Six Months 2024 Financial and Operational Results
Company achieved $57.2 million in total net revenue and $55.0 million in net product revenue for the second quarter of...
authID Inc. Partners with Kaiasoft.com to Elevate Best-In-Class SaaS Applications with Biometric Identity Assurance
authID to stop malicious, generative AI-driven cyberattacks and deepfakes for Kaiasoft.com SaaS clients across America and EuropeDENVER, July 31, 2024...
Appendix 4C – Q4 FY24 Quarterly Cash Flow Report
HighlightsMELBOURNE, Australia and SAN FRANCISCO, July 31, 2024 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the...
Athira Pharma Presents Preclinical Data Demonstrating New Insights into the Mechanism by Which Fosgonimeton Protects Neurons from Alzheimer’s Disease-Related Pathology at the Alzheimer’s Association International Conference (AAIC) 2024
Fosgonimeton mitigated amyloid-β-induced toxicity, lowered pTau levels and reduced disruption of protein clearance mechanisms that may contribute to pTau pathologyRead...
Arhaus to Report Second Quarter 2024 Financial Results on August 8, 2024
BOSTON HEIGHTS, Ohio, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Arhaus (NASDAQ: ARHS), a rapidly growing lifestyle brand and omni-channel retailer...
Ardelyx Announces Publication of Two Plain Language Summaries from XPHOZAH® (tenapanor) Clinical Trials in Current Medical Research and Opinion
WALTHAM, Mass., July 31, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to...
Alzamend Neuro Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
Contacts Email: Info@Alzamend.com or call: 1-844-722-6333 Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel...
Allogene Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update
SOUTH SAN FRANCISCO, Calif., July 31, 2024 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the...
Avalon’s Laboratory Services MSO Launches DNA Testing Kit for Predisposition to Opioid Addiction
FREEHOLD, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon” or the “Company”) (NASDAQ: ALBT), a developer of...
Alarum to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
Tel Aviv, Israel, July 31, 2024 (GLOBE NEWSWIRE) -- Alarum Technologies Ltd. (Nasdaq, TASE: ALAR) (“Alarum” or the “Company”), a...
Airgain Expands Into Growing Middle East Market With Waseela Partnership
Collaboration will integrate Airgain's advanced wireless solutions for cost effective and fast deployment to deliver superior 5G customer experiences in...
Agios Reports Business Highlights and Second Quarter 2024 Financial Results
– Reported Positive Topline Data from Phase 3 ENERGIZE-T Study; Expect to File sNDA Based on ENERGIZE and ENERGIZE-T Studies Encompassing...
Affirm to Announce Fourth Quarter and Fiscal Year 2024 Results on August 28, 2024
Contacts Investor Relations ir@affirm.com Media press@affirm.com Affirm Holdings, Inc. (NASDAQ: AFRM), the payment network that empowers consumers and helps merchants...
Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044
GLEN ALLEN, Va., July 31, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage...
ACI Worldwide, Inc. Reports Financial Results for the Quarter Ended June 30, 2024
Q2 2024 HIGHLIGHTS Revenue up 16% versus Q2 2023 Net income of $31 million, up $38 million from Q2 2023...
AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024
AC Immune Unveils Novel Therapeutic Antibody Drug Conjugate (ADC) Technology for Improved Efficacy in Neurodegenerative Diseases at AAIC 2024Lausanne, Switzerland,...
Achieve Life Sciences Announces FDA Grants Breakthrough Therapy Designation to Cytisinicline for the Treatment of E-Cigarette or Vaping Nicotine Dependence
SEATTLE and VANCOUVER, British Columbia, July 31, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical...
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in First-line Pancreatic Cancer
- IMM-1-104 Fast Track designation now granted for the treatment of both first and second-line pancreatic ductal adenocarcinoma (PDAC); provides...
Inspire Veterinary Partners to Present at Sidoti Virtual Investor Conference August 14
VIRGINIA BEACH, VA / ACCESSWIRE / July 31, 2024 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) ("Inspire" or the "Company"), an...
DallasNews Corporation Announces Second Quarter 2024 Financial Results
DALLAS, July 30, 2024 (GLOBE NEWSWIRE) -- DallasNews Corporation (Nasdaq: DALN) (the “Company”) today reported second quarter 2024 net income of...
LAKESIDE ENTERS INTO LOGISTICS AGREEMENT WITH LEADING E-COMMERCE PLATFORM
Empowers Online Marketplace Sellers with Seamless Cross-Border Fulfillment Itasca, IL, July 31, 2024 (GLOBE NEWSWIRE) -- Lakeside Holding Limited (“Lakeside”...
Meihua International Medical Technologies Facilitates World’s Second* 5G Remote Robot-Assisted Lobectomy
YANGZHOU, China, July 31, 2024 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (Nasdaq: MHUA), a...
Zevra Therapeutics to Report Second Quarter 2024 Financial Results
CELEBRATION, Fla., July 30, 2024 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company) a rare disease...
Dentsply Sirona Reports Second Quarter 2024 Results and Announces Second Phase of Transformation
CHARLOTTE, N.C., July 31, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced...
Xcel Energy Inc. Board Declares Dividend on Common Stock
Contacts Xcel Energy, Minneapolis Shareholder Services Darin Norman (612) 337-2310 or Paul Johnson, Vice President, Treasurer & Investor Relations (612)...
WiSA Association Quantifies Market Penetration of WiSA E – 43% of the Android-based HDTV Market Currently Licensed
Company now building interoperable WiSA E speaker ecosystem to support WiSA E-enabled HDTVs Contacts Investor: David Barnard, LHA Investor Relations,...
Weibo Corporation to Report Second Quarter 2024 Financial Results on August 22, 2024
BEIJING, July 31, 2024 /PRNewswire/ -- Weibo Corporation (Nasdaq: WB and HKEX: 9898), a leading social media for people to create,...
Viasat Introduces Wearable Secure Wireless Hub for Advanced Network and Edge Communications
Secure Wireless Hub is a next-generation body-worn tactical communications system for dismounted operations CARLSBAD, Calif., July 30, 2024 /PRNewswire/ -- Viasat...
Verisk Reports Second-Quarter 2024 Financial Results
JERSEY CITY, N.J., July 31, 2024 (GLOBE NEWSWIRE) -- Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider,...
Vislink to Report Second Quarter 2024 Financial Results on Wednesday, August 14, 2024, at 8:30 a.m. ET
Mt. Olive, NJ, July 30, 2024 (GLOBE NEWSWIRE) -- Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL), a global...